Generic Name : Meningococcal C,Y and Haemophilus B Tetanus Toxoid Therapeutic Classification : Immunizing Agents ICD Code : Y58.9
International- Menhibrix. Why it is prescribed (Indications) :
This medication is a combination vaccine, prescribed for preventing of invasive disease caused by Neisseria meningitidis serogroups C and Y and Haemophilus influenzae type B. When it is not to be taken (Contraindications): Hypersensitivity.
Dosage & When it is to be taken :
Four doses (0.5 mL each) by intramuscular injection at 2, 4, 6, and 12 through 15 months of age. The first dose may be given as early as 6 weeks of age. The fourth dose may be given as late as 18 months of age. How it should be taken :
It comes as a solution for injection to be administered by a healthcare provider into the large muscle. Side Effects :
Most Common - Irritability, drowsiness, loss of appetite, and fever.
* Avoid excess dosage. Storage Conditions :
Store the medication as directed by your physician.
Comment & Contribute
Ask an Expert